Search

Home > New FDA Approvals > 121 - rucaparib for ovarian cancer; antimicrobial post-therapy gel; digital health clearances in 2018; FDA releases plan for Biosimilar User Fee Act
Podcast: New FDA Approvals
Episode:

121 - rucaparib for ovarian cancer; antimicrobial post-therapy gel; digital health clearances in 2018; FDA releases plan for Biosimilar User Fee Act
Category: Science & Medicine
Duration: 00:09:06
Publish Date: 2018-04-09 06:00:00
Description:

April 9, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 

1:27 FDA expands rucaparib approval to include maintenance treatment of recurrent ovarian cancer http://www.ascopost.com/News/58705

2:55 US FDA approves Sonoma Pharma's antimicrobial post-therapy gel http://www.pharmabiz.com/NewsDetails.aspx?aid=108227&sid=2

4:36 FDA digital health clearances and news in Q1 2018 http://www.mobihealthnews.com/content/roundup-fda-digital-health-clearances-and-news-q1-2018

6:32 FDA Releases 5-Year Financial Plan for Biosimilar User Fee Act http://www.centerforbiosimilars.com/news/fda-releases-5year-financial-plan-for-biosimilar-user-fee-act

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0